Perrigo Company Overview
- Year Founded
-
1887
- Status
-
Public
- Employees
-
8,379
- Stock Symbol
-
PRGO
- Investments
-
52
- Share Price
-
$27.53
- (As of Friday Closing)
Perrigo Company General Information
Description
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Contact Information
Website
www.perrigo.comCorporate Office
- The Sharp Building
- Hogan Place
- Dublin
- Ireland
Corporate Office
- The Sharp Building
- Hogan Place
- Dublin
- Ireland
Perrigo Company Timeline
Perrigo Company Stock Performance
As of 11-Jul-2025, Perrigo Company’s stock price is $27.53. Its current market cap is $3.75B with 137M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $27.53 | $27.27 | $23.14 - $30.93 | $3.75B | 137M | 1.19M | -$1.31 |
Perrigo Company Financials Summary
As of 31-Mar-2025, Perrigo Company has a trailing 12-month revenue of $4.34B.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 6,885,600 | 6,798,459 | 8,021,899 | 8,232,169 |
| Revenue | 4,335,200 | 4,373,400 | 4,655,600 | 4,451,600 |
| EBITDA | 534,300 | 433,000 | 525,000 | 355,500 |
| Net Income | (180,300) | (171,800) | (12,700) | (140,600) |
| Total Assets | 9,759,800 | 9,647,700 | 10,809,100 | 11,017,300 |
| Total Debt | 3,627,500 | 3,618,100 | 4,073,400 | 4,106,600 |
Perrigo Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Perrigo Company Comparisons
Industry
Financing
Details
Perrigo Company Competitors (37)
One of Perrigo Company’s 37 competitors is Dr. Reddy's Laboratories, a Corporation company based in Hyderabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories | Corporation | Hyderabad, India | ||||
| Knight Therapeutics | Corporation | Montreal, Canada | ||||
| Eisai | Corporation | Tokyo, Japan | ||||
| Viatris | Corporation | Canonsburg, PA | ||||
| Sandoz Group | Corporation | Basel, Switzerland |
Perrigo Company Patents
Perrigo Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240415163-A1 | Flavor banding of capsules | Pending | 16-Jun-2023 | ||
| US-11793876-B2 | Bulk polyethylene glycol compositions | Active | 18-Oct-2019 | ||
| US-20210113698-A1 | Bulk polyethylene glycol compositions | Active | 18-Oct-2019 | ||
| US-11701350-B2 | Dextromethorphan extended release pharmaceutical composition | Active | 22-Jul-2019 | ||
| US-20210023073-A1 | Dextromethorphan extended release pharmaceutical composition | Active | 22-Jul-2019 | A61K31/485 |
Perrigo Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Perrigo Company Investments & Acquisitions (52)
Perrigo Company’s most recent deal was a Corporate Asset Purchase with Nestle (Gateway Infant Formula Plant based in Eau Claire, Wisconsin) for . The deal was made on 01-Nov-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Nestle (Gateway Infant Formula Plant based in Eau Claire, Wisconsin) | 01-Nov-2022 | Corporate Asset Purchase | Buildings and Property | ||
| HRA Pharma | 29-Apr-2022 | Merger/Acquisition | Pharmaceuticals | ||
| Sanofi (Emolium, Iwostin and Loxon in Paris, France) | 02-Nov-2020 | Corporate Asset Purchase | Buildings and Property | ||
| Kazmira | 17-Jun-2020 | Corporate | Real Estate Investment Trusts (REITs) | ||
| Dr. Fresh | 02-Apr-2020 | Merger/Acquisition | Personal Products |
Perrigo Company ESG
Risk Overview
Risk Rating
Updated July, 01, 2025
33.85 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile
Household Products
Industry
of 104
Rank
Percentile
Personal Products
Subindustry
of 81
Rank
Percentile
Perrigo Company Exits (5)
Perrigo Company’s most recent exit was on 28-Aug-2015 from Mitchell-Vance Laboratories. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Mitchell-Vance Laboratories | 28-Aug-2015 | Completed |
|
||
| Rosemont Pharmaceuticals | 11-Feb-2013 | Completed |
|
||
| IVC Brunel Healthcare | 01-Jan-2003 | Completed |
|
||
| Sagmel | 01-Jan-1997 | Completed |
|
||
| Vi-Jon | 01-Dec-1994 | Merger/Acquisition | Completed |
Perrigo Company Affiliates
Subsidiaries (13)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Perrigo Ireland 10 Unlimited Company | Dublin, Ireland | 2015 | |
| Perrigo Ireland 5 Unlimited Company | Dublin, Ireland | 2015 | |
| Omega Pharma Austria Health Care | Vienna, Austria | 2013 | |
| Perrigo Finance Unlimited Company | Dublin, Ireland | 2004 | |
| Perrigo Uk Acquisition | Braunton, United Kingdom | 2001 |
Perrigo Company FAQs
-
When was Perrigo Company founded?
Perrigo Company was founded in 1887.
-
Where is Perrigo Company headquartered?
Perrigo Company is headquartered in Dublin, Ireland.
-
What is the size of Perrigo Company?
Perrigo Company has 8,379 total employees.
-
What industry is Perrigo Company in?
Perrigo Company’s primary industry is Pharmaceuticals.
-
Is Perrigo Company a private or public company?
Perrigo Company is a Public company.
-
What is Perrigo Company’s stock symbol?
The ticker symbol for Perrigo Company is PRGO.
-
What is the current stock price of Perrigo Company?
As of 11-Jul-2025 the stock price of Perrigo Company is $27.53.
-
What is the current market cap of Perrigo Company?
The current market capitalization of Perrigo Company is $3.75B.
-
What is Perrigo Company’s current revenue?
The trailing twelve month revenue for Perrigo Company is $4.34B.
-
Who are Perrigo Company’s competitors?
Dr. Reddy's Laboratories, Knight Therapeutics, Eisai, Viatris, and Sandoz Group are some of the 37 competitors of Perrigo Company.
-
What is Perrigo Company’s annual earnings per share (EPS)?
Perrigo Company’s EPS for 12 months was -$1.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
